Pharmacist fined for natural therapies

Sep 14, 2007

A Tennessee pharmacist has received a $1 million fine for treating customers at his health-food store with juices and dietary supplements.

The Tennessee Board of Medical Examiners ruled in May that Larry Rawdon's practice of treating ailments such as cancer with alternative therapies is harmful, The Nashville Tennessean reported Thursday.

The $1 million fine is the largest the board has ever handed out, the newspaper said.

A former patient of the Hohenwald, Tenn., pharmacist has created the group MyHealthMyChoice to raise money for Rawdon's fine and petition to make alternative health care legal in Tennessee, the newspaper reported.

Copyright 2007 by United Press International

Explore further: Early use of tracheostomy for mechanically ventilated patients not associated with improved survival

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

People on higher incomes are happier with new knees

22 hours ago

Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University ...

New search engine finds rare diagnoses

23 hours ago

Doctors are trained to think "common disease" when they meet patients in their practices, and as they rarely or never meet a rare disease, it often takes many years to reach the right diagnosis. A new search tool called FindZebra ...

User comments : 0

More news stories

Study finds COPD is over-diagnosed among uninsured patients

More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive ...

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...